Natural Product (NP) Details
General Information of the NP (ID: NP2616) | |||||
---|---|---|---|---|---|
Name |
Curdione
|
||||
Synonyms |
Curdione; 13657-68-6; Germacr-1(10)-ene-5,8-dione; Cyclodecene-1,4-dione, 6,10-dimethyl-3-(1-methylethyl)-, (3S-(3R*,6E,10R*))-; SCHEMBL3297349; CHEBI:81131; HY-N0353; MFCD28977990; s9164; ZINC12153222; CCG-266841; 6-Cyclodecene-1,4-dione, 6,10-dimethyl-3-(1-methylethyl)-, (3S-(3R*,6E,10R*))- (9CI); AS-72874; N1432; C17493; Q15410914; (3S,6E,10S)-6,10-dimethyl-3-(propan-2-yl)cyclodec-6-ene-1,4-dione
Click to Show/Hide
|
||||
Species Origin | Curcuma zedoaria ... | Click to Show/Hide | |||
Curcuma zedoaria | |||||
Disease | Renal cell carcinoma [ICD-11: 2C90] | Phase 2 | [1] | ||
Structure |
![]() |
Click to Download Mol2D MOL |
|||
Click to Show/Hide the Molecular Information and External Link(s) of This Natural Product | |||||
Formula |
C15H24O2
|
||||
PubChem CID | |||||
Canonical SMILES |
CC1CCC=C(CC(=O)C(CC1=O)C(C)C)C
|
||||
InChI |
1S/C15H24O2/c1-10(2)13-9-14(16)12(4)7-5-6-11(3)8-15(13)17/h6,10,12-13H,5,7-9H2,1-4H3/b11-6+/t12-,13-/m0/s1
|
||||
InChIKey |
KDPFMRXIVDLQKX-NHFJXKHHSA-N
|
||||
CAS Number |
CAS 13657-68-6
|
||||
ChEBI ID | |||||
Herb ID | |||||
SymMap ID | |||||
TCMSP ID |
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. A List of Drug(s) Whose Efficacy can be Enhanced by This NP | ||||||
Germacrone | Idiopathic pulmonary fibrosis | Click to Show/Hide the Molecular Data of This Drug | ||||
Achieving Therapeutic Synergy | Click to Show/Hide | |||||
Representative Experiment Reporting the Effect of This Combination | [2] | |||||
Detail(s) |
Combination Info
![]() |
|||||
Molecule(s)
Regulation |
Down-regulation | Expression | BCL-xL | Molecule Info |
Pathway MAP
|
|
In-vitro Model | MDA-MB-231 | CVCL_0062 | Breast adenocarcinoma | Homo sapiens | ||
MCF-7 | CVCL_0031 | Invasive breast carcinoma | Homo sapiens | |||
Experimental
Result(s) |
Germacrone enhanced furanodiene's anti-proliferative effect. | |||||
β. A List of Drug(s) Whose Adverse Effect can be Decreased by This NP | ||||||
Doxorubicin | Solid tumour/cancer | Click to Show/Hide the Molecular Data of This Drug | ||||
Decreasing Adverse Drug Reaction | Click to Show/Hide | |||||
Representative Experiment Reporting the Effect of This Combination | [3] | |||||
Detail(s) |
Combination Info
![]() |
|||||
Molecule(s)
Regulation |
Down-regulation | Expression | BCL-2 | Molecule Info |
Pathway MAP
|
|
In-vitro Model | H9c2(2-1) | CVCL_0286 | Healthy | Rattus norvegicus | ||
Experimental
Result(s) |
Curdione ameliorated doxorubicin-induced cardiotoxicity through suppressing oxidative stress and activating Nrf2/HO-1 pathway. |

